EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Is benefit sharing with research participants lawful in South Africa? An unexplored question in the governance of genomics research

Donrich Thaldar iD, Bonginkosi Shozi iD

Journal of Law and the Biosciences · 01.01.2023 · 10 (1)

DOI: 10.1093/jlb/lsad018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Law and the Biosciences, online erschienen am 28.06.2023. Verfasst von Donrich Thaldar und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Law, University of KwaZulu-Natal, Durban, South Africa. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health, US National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advocacy in favour of benefit sharing with research participants in genomics research that is conducted in South Africa, there has been little critical legal engagement with this concept. That is what this article provides by posing the hitherto unexplored—but foundational—question: Is benefit sharing with research participants lawful in South Africa? The answer is clearly ‘no’. South African law provides that it is unlawful to provide any financial or other reward to research participants for donating biospecimens—except for reimbursement of reasonable costs incurred. Accordingly, benefit sharing would be unlawful. The ramifications of this conclusion are far-reaching. Most pertinently, should any benefit-sharing agreements with research be put into practice, such agreements would be unenforceable and would expose all parties involved—including foreign collaborators—to criminal prosecution. The solution for proponents of benefit sharing in South Africa would be to lobby the South African government to revise the relevant law. However, as long as the law remains as it currently is, institutions and individuals all over the world who are involved in genomics research in South Africa would be well advised to comply with the law by not engaging in benefit sharing with research participants.

Autor:innen und Institutionen

  • School of Law, University of KwaZulu-Natal, Durban, South Africa.
  • Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, Cambridge, MA, USA.
  • Institute for Practical Ethics, University of California San Diego, San Diego, CA, USA.

ORCID-Profile: Donrich Thaldar, Bonginkosi Shozi

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health
  • US National Institutes of Health
  • Harnessing Data Science for Health Discovery and Innovation in Africa

Zitieren

APA

Thaldar, D., & Shozi, B. (2023). Is benefit sharing with research participants lawful in South Africa? An unexplored question in the governance of genomics research. Journal of Law and the Biosciences, 10(1). https://doi.org/10.1093/jlb/lsad018

Vancouver

Thaldar D, Shozi B. Is benefit sharing with research participants lawful in South Africa? An unexplored question in the governance of genomics research. Journal of Law and the Biosciences. 2023;10(1). doi:10.1093/jlb/lsad018

BibTeX
@article{Thaldar2023,
  author = {Thaldar, Donrich and Shozi, Bonginkosi},
  title = {Is benefit sharing with research participants lawful in South Africa? An unexplored question in the governance of genomics research},
  journal = {Journal of Law and the Biosciences},
  year = {2023},
  volume = {10},
  number = {1},
  doi = {10.1093/jlb/lsad018}
}
Kostenlos starten →